The peak of COVID-19 infections might be behind us – at least until the next “variant of concern” of the SARS-CoV-2 virus appears – but the scourge of long COVID lives on. And on.
Fluvoxamine
If there is a single lesson to be learned from three years of the pandemic, it's that if you're going to try to treat Covid with a drug, it had better be a direct-acting antiviral drug. (1)
ACSH relies on donors like you. If you enjoy our work, please contribute.
Make your tax-deductible gift today!
Popular articles
ACSH Podcasts
